2006
DOI: 10.1016/s0168-8278(06)80237-0
|View full text |Cite
|
Sign up to set email alerts
|

236 The role of somatostatin and octreotide in preventing the post endoscopic increase of HVPG in cirrhotics with bleeding varices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Interestingly there was a sustained rise of portal pressure after sclerotherapy, but not after band ligation. In addition, Vlachogiannakos et al [17] showed that somatostatin but not octreotide effectively prevents the post-endoscopic increase of HVPG. With the prognostic association of high HVPG with the course of bleeding (using vasoactive drugs and endoscopic therapy) and mortality, a randomized study showed that urgent TIPS in patients with HVPG >20 mmHg protected against continued or repeated bleeding and reduced mortality [15].…”
mentioning
confidence: 99%
“…Interestingly there was a sustained rise of portal pressure after sclerotherapy, but not after band ligation. In addition, Vlachogiannakos et al [17] showed that somatostatin but not octreotide effectively prevents the post-endoscopic increase of HVPG. With the prognostic association of high HVPG with the course of bleeding (using vasoactive drugs and endoscopic therapy) and mortality, a randomized study showed that urgent TIPS in patients with HVPG >20 mmHg protected against continued or repeated bleeding and reduced mortality [15].…”
mentioning
confidence: 99%